The weekly litigation news digest is live. Subscribe now

IP Verse

Rapid-Acting Insulin Compositions - EP3233108

The patent EP3233108 was granted to ELI Lilly on Mar 30, 2022. The application was filed on Dec 9, 2015 under application number EP15817678A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3233108

ELI LILLY
Application Number
EP15817678A
Filing Date
Dec 9, 2015
Status
Granted And Under Opposition
Feb 25, 2022
Publication Date
Mar 30, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
SCORPIODec 30, 2022SAGITTARIUSADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2012178675
DESCRIPTIONUS2013231281
DESCRIPTIONUS2014113856
DESCRIPTIONUS2015065423
EXAMINATIONUS2013231281
EXAMINATIONWO2010102020
INTERNATIONAL-SEARCH-REPORTUS2014357554
INTERNATIONAL-SEARCH-REPORTWO2013158618
OPPOSITIONUS2013231281
OPPOSITIONUS2014357554
OPPOSITIONUS2016082106
OPPOSITIONWO2010102020
OPPOSITIONWO2012174478
OPPOSITIONWO2013158618
OPPOSITIONWO2015120457
OPPOSITIONWO2015173427

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents